Abstract | OBJECTIVE: Antisperm antibody binding to acrosin was investigated by Western Blotting. The clinical significance of this binding specificity was assessed in a 2-year clinical follow-up. DESIGN: SETTING: The patients were followed in an outpatient setting by private infertility specialists. PATIENTS: Sixty-five consecutive infertile referral patients with positive antisperm antibody were evaluated. Clinical follow-up was obtained on 8 of 9 females with evidence of antibody binding to acrosin and 19 of 26 females with no specific binding to acrosin. INTERVENTIONS:
Prednisone therapy was given during six courses of intrauterine insemination with husband's sperm. All treatment decisions were made by private physicians independent of the acrosin-binding result. MAIN OUTCOME MEASURES: Pregnancy status was obtained as part of a 2-year follow-up. RESULTS:
Acrosin-binding specificity was demonstrated in 10 (15%) of the 65 patients. Two of the 8 women (25%) with antibody binding to acrosin and 6 of the 19 women (32%) with antisperm antibodies but no specific binding to acrosin delivered normal children. CONCLUSIONS: Although antibody-binding specificity to acrosin could be demonstrated, a 2-year clinical follow-up showed no difference in pregnancy rates when compared with women with antisperm antibodies showing no binding specificity to acrosin.
|
Authors | S E Howe, S L Grider, D M Lynch, L M Fink |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 55
Issue 6
Pg. 1176-82
(Jun 1991)
ISSN: 0015-0282 [Print] United States |
PMID | 2037111
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Autoantibodies
- Acrosin
- Prednisone
|
Topics |
- Acrosin
(immunology)
- Adult
- Autoantibodies
(immunology)
- Blotting, Western
- Chromatography, Gel
- Enzyme-Linked Immunosorbent Assay
- Female
- Follow-Up Studies
- Humans
- Infertility, Female
(immunology)
- Insemination, Artificial, Homologous
- Male
- Prednisone
(therapeutic use)
- Pregnancy
- Spermatozoa
(immunology)
|